Skip to main content
SpringerLink
Log in

Pregnancy Outcome and Metabolic Syndrome

  • Chapter
  • First Online:
Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health

Part of the book series: ISGE Series ((ISGE))

  • 516 Accesses

Abstract

Obesity and metabolic disorders in women of reproductive age is a growing health problem; in the USA, pre-pregnancy obesity in women increased from 13.0% in 1993–1994 to 22.0% in 2002–2003, while the rate of obese European women ranges between 6 and 37% [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim SY, Dietz PM, England L, Morrow B, Callaghan WM. Trends in pre-pregnancy obesity in nine states, 1993–2003. Obesity (Silver Spring) 2007;15:986–993.

    Google Scholar 

  2. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8:200.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr. 2010;64:1043–51.

    Article  CAS  PubMed  Google Scholar 

  4. Denis GV, Obin MS. ‘Metabolically healthy obesity’: origins and implications. Mol Asp Med. 2013;34:59–70.

    Article  CAS  Google Scholar 

  5. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond). 2010;119(3):123–9.

    Article  CAS  Google Scholar 

  6. Moussa HN, Alrais MA, Leon MG, Abbas EL, Sibai BM. Obesity epidemic: impact from preconception to postpartum. Future Sci OA. 2016;2(3):FSO137.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017 Feb 8;356:j1.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bartha JL, Bugatto FG, Macías RF, González NL, Delgado RC, Vivancos BH. Metabolic syndrome in Normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 2008;137:178–84.

    Article  CAS  PubMed  Google Scholar 

  9. Santos S, Voerman E, Amiano P, Barros H, Beilin LJ, Bergström A. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European. N Am Aust Cohorts BJOG. 2019;126(8):984.

    CAS  Google Scholar 

  10. Boots CE, Bernardi LA, Stephenson MD. Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril. 2014;102:455–9.

    Article  PubMed  Google Scholar 

  11. Gilboa SM, Correa A, Botto LD, et al; National Birth Defects Prevention Study. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 2010; 202(1):51, e1–e51, e10.

    Google Scholar 

  12. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275(14):1089–92.

    Article  CAS  PubMed  Google Scholar 

  13. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014; 311(15):1536–46.)

    Google Scholar 

  14. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14(3):368–74.

    Article  PubMed  Google Scholar 

  15. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18(2):234–9.

    Article  PubMed  Google Scholar 

  16. Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLoS One. 2013;8(4):e61627.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ, HAPO Study Cooperative Research Group. The hyperglycemia and adverse pregnancy outcome study: Associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012 Apr; 35(4):780–786.

    Google Scholar 

  18. Lisonkova S, Muraca GM, Potts J, et al. Association between prepregnancy body mass index and severe maternal morbidity. JAMA. 2017;318:1777–86.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kawakita T, Reddy UM, Landy HJ, Iqbal SN, Huang CC, Grantz KL. Indications for primary cesarean delivery relative to body mass index. Am J Obstet Gynecol. 2016;215:515e1–9.

    Article  Google Scholar 

  20. Kim SS, Zhu Y, Grantz KL, et al. Obstetric and neonatal risks among obese women without chronic disease. Obstet Gynecol. 2016;128:104–12.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Moayeri M, Heida KY, Franx A, Spiering W, de Laat MW, Oudijk MA. Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch Gynecol Obstet. 2017;295:313–23.

    Article  CAS  PubMed  Google Scholar 

  22. Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015;122:643–51.

    Article  CAS  PubMed  Google Scholar 

  23. Barrett HL, Dekker Nitert M, McIntyre HD, Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care. 2014;37:1484–93.

    Article  CAS  PubMed  Google Scholar 

  24. Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C, et al. Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol. 2009;170:829–36.

    Article  PubMed  Google Scholar 

  25. Grieger JA, Bianco-Miotto T, Grzeskowiak LE, Leemaqz SQ, Poston L, McCowan MLID.

    Google Scholar 

  26. Kenny LC, Myers JE, Walker JJ, Dekker GA, Roberts CT. Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women PLoS Med. 2018:15(12).

    Google Scholar 

  27. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG. 2006;113(10):1141–7.

    Article  CAS  PubMed  Google Scholar 

  28. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.

    Article  CAS  PubMed  Google Scholar 

  29. Jones HN, Jansson T, Powell TL. IL-6 stimulates system a amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol. 2009;297:C1228–35.

    Article  CAS  PubMed  Google Scholar 

  30. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta. 2011;32(2):121–7.

    Article  CAS  PubMed  Google Scholar 

  31. Aye IL, Ramirez VI, Gaccioli F, Lager S, Jansson T, Powell T. Activation of placental inflammasomes in pregnant women with high BMI. Reprod Sci. 2013;20(S3):73A–73.

    Google Scholar 

  32. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab. 2003;284(6):E1098–105.

    Article  CAS  PubMed  Google Scholar 

  33. Masuyama H, Hiramatsu Y. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology. 2012;153:2823–30.

    Article  CAS  PubMed  Google Scholar 

  34. Shah TJ, Courtney EL, Walsh SW. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci. 2010;17(2):116–24.

    CAS  PubMed  Google Scholar 

  35. Romero R, Erez O, Hüttemann M, Maymon E, Panaitescu B, Conde-Agudelo A, Pacora P, Yoon BH, Grossman LI. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017 Sep;217(3):282–302.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Brett KE, Ferraro ZM, Yockell-Lelievre J, Gruslin A, Adamo KB. Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta. Int J Mol Sci. 2014 Sep 12;15(9):16153–85.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Ruiz-Palacios M, Ruiz-Alcaraz AJ, Sanchez-Campillo M, Larqué E. Role of insulin in placental transport of nutrients in gestational diabetes mellitus. Ann Nutr Metab. 2017;70:16–25.

    Article  CAS  PubMed  Google Scholar 

  38. Valdés E, Sepúlveda-Martínez A, Manukián B. Parra-Cordero M assessment of pregestational insulin resistance as a risk factor of preeclampsia. Gynecol Obstet Investig. 2014;77(2):111–6.

    Article  CAS  Google Scholar 

  39. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, Varner MW, Wapner RJ, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011; 204(4):327

    Google Scholar 

  40. Alsnes IV, Janszky I, Forman MR, Vatten LJ, Økland I A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol. 2014; 211(6):657

    Google Scholar 

  41. Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W. Maternal pre-pregnancy obesity is associated with higher risk of placental pathological lesions. Placenta. 2014;35:563–9.

    Article  PubMed  Google Scholar 

  42. Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101–14.

    Article  CAS  PubMed  Google Scholar 

  43. Tanaka K, Yamada K, Matsushima M, Izawa T, Furukawa S, Kobayashi Y, Iwashita M. Increased maternal insulin resistance promotes placental growth and decreases placental efficiency in pregnancies with obesity and gestational diabetes mellitus. J Obstet Gynaecol Res. 2018 Jan;44(1):74–80.

    Article  CAS  PubMed  Google Scholar 

  44. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9:936–43.

    Article  CAS  PubMed  Google Scholar 

  45. Thadhani R, Ecker JL, Mutter WP, Wolf M, K. Smirnakis KV, Sukhatme VP. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension. 2004;43:988–92.

    Article  CAS  PubMed  Google Scholar 

  46. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. J Clin Invest. 2004 Dec;114(12):1752–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006 Apr 13;440(7086):944–8.

    Article  CAS  PubMed  Google Scholar 

  48. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2006;30:400–18.

    Article  CAS  Google Scholar 

  49. Boden G. Obesity, insulin resistance, and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18:139–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005;60(12):807–16.

    Article  PubMed  Google Scholar 

  51. Sultana Z, Maiti K, Dedman L, Smith R. Is there a role for placental senescence in the genesis of obstetric complications and fetal growth restriction? Am J Obstet Gynecol. 2018 Feb;218(2S):S762–73.

    Article  PubMed  Google Scholar 

  52. Sultana Z, Maiti K, Aitken J, Morris J, Dedman L, Smith R Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes. Am J Reprod Immunol. 2017;77(5).

    Google Scholar 

  53. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, Steinhorn RH. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2008;295(6):L979–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Matsubara K, Higaki T, Matsubara Y, Nawa A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci. 2015;16(3):4600–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab. 2014;307(5):E419–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Weight change and the risk of gestational diabetes in obese women. Glazer NL, Hendrickson AF, Schellenbaum GD, Mueller BA. Epidemiology. 2004;15(6):733–7.

    Google Scholar 

  57. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006;368(9542):1164–70. https://doi.org/10.1016/S0140-6736(06)69473-7.

  58. Ehrlich SF, Hedderson MM, Feng J, Davenport ER, Gunderson EP, Ferrara A. Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet Gynecol. 2011;117(6):1323–30.

    Google Scholar 

  59. Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560–74.

    Article  CAS  PubMed  Google Scholar 

  60. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017 Nov;6(8):647–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Poston L, Caleyachetty R, Cnattingius S, Corvalán C, Uauy R, Herring S, Gillman MW. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016 Dec;4(12):1025–36.

    Article  PubMed  Google Scholar 

  62. Dodd JM, Cramp C, Sui Z, Yelland LN, Deussen AR, Grivell RM, Moran LJ, Crowther CA, Turnbull D, McPhee AJ, Wittert G, Owens JA, Robinson JS; LIMIT Randomised Trial Group. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on maternal diet and physical activity: the LIMIT randomised trial. BMC Med 2014;12:161.

    Google Scholar 

  63. Simmons D, Devlieger R, van Assche A, Jans G, Galjaard S, Corcoy R, Adelantado JM, Dunne F, Desoye G, Harreiter J, Kautzky-Willer A, Damm P, Mathiesen ER, Jensen DM, Andersen L, Lapolla A, Dalfrà MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Hill D, Snoek FJ. Jelsma JG, van Poppel MN effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study. J Clin Endocrinol Metab. 2017 Mar 1;102(3):903–13.

    PubMed  Google Scholar 

  64. Koivusalo SB, Rönö K, Klemetti MM, Roine RP, Lindström J, Erkkola M, Kaaja RJ, Pöyhönen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinilä J, Kautiainen H, Eriksson JG, Stach-Lempinen B. Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial. Diabetes Care. 2016 Jan;39(1):24–30.

    Article  CAS  PubMed  Google Scholar 

  65. Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017 Nov 13;11(11):CD010443.

    PubMed  Google Scholar 

  66. Barquiel B, Herranz L, Meneses D, Moreno Ó, Hillman N, Burgos MÁ, Bartha JL. Optimal gestational weight gain for women with gestational diabetes and morbid obesity. Matern Child Health J. 2018 Sep;22(9):1297–305.

    Article  PubMed  Google Scholar 

  67. Zeng XL, Zhang YF, Tian Q, Xue Y, An RF. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore). 2016 Sep;95(36):e4526.

    Article  CAS  Google Scholar 

  68. Chiswick C, Reynolds RM, Denison F, Drake AJ, Forbes S, Newby DE, Walker BR, Quenby S, Wray S, Weeks A, Lashen H, Rodriguez A, Murray G, Whyte S, Norman JE. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015 Oct;3(10):778–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434–43. doi.

    Google Scholar 

  70. Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, Senadheera S, Illanes SE, Kaitu'u-Lino TJ, Tong S. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. Am J Obstet Gynecol. 2016;214(3):356.

    Google Scholar 

  71. Rowan JA, Rush EC, Plank LD, Lu J, Obolonkin V, Coat S, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016;12(10):1181–96.

    Article  CAS  PubMed  Google Scholar 

  73. Martis R, Crowther CA, Shepherd E, Alsweiler J, Downie MR, Brown J. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018;8(8):CD012327.

    PubMed  Google Scholar 

  74. D’Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, et al. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36(4):854–8.

    Article  PubMed  PubMed Central  Google Scholar 

  75. D’Anna R, Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women. A randomized controlled trial. Obstetrics. 2015;126(2):310–5.

    Article  CAS  Google Scholar 

  76. Facchinetti F, Pignatti L, Interdonato ML, Neri I, Bellei G, D’Anna R. Myoinositol supplementation in pregnancies at risk for gestational diabetes. Interim analysis of a randomized controlled trial. Am J Obstet Gynecol 2013;208(Suppl 1):S36.

    Google Scholar 

  77. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia Obstetrics & Gynecology 2019;133(1):e1-e25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Obstetrics and Gynecology, Department of Biomedical, Experimental, and Clinical Sciences, Careggi University Hospital, University of Florence, Florence, Italy

    Serena Ottanelli, Serena Simeone, Caterina Serena, Marianna Pina Rambaldi, Sara Zullino & Federico Mecacci

Authors
  1. Serena Ottanelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serena Simeone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caterina Serena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marianna Pina Rambaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sara Zullino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Federico Mecacci
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

  2. Endocrinology Department, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain

    Lourdes Ibáñez

  3. Department of Endocrinology, Diabetology, Wrocław Medical University, Wroclaw, Poland

    Andrzej Milewicz

  4. Obstetrics and Gynecology, Gynaecworld, Mumbai, India

    Duru Shah

Rights and permissions

Reprints and permissions

Copyright information

© 2021 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ottanelli, S., Simeone, S., Serena, C., Rambaldi, M.P., Zullino, S., Mecacci, F. (2021). Pregnancy Outcome and Metabolic Syndrome. In: Genazzani, A.R., Ibáñez, L., Milewicz, A., Shah, D. (eds) Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-63650-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-63650-0_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-63649-4

  • Online ISBN: 978-3-030-63650-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation